(Q33490839)

English

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

scientific article published on 5 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

fatty liver disease

1 reference

based on heuristic

inferred from title

object named as

Luca Miele

5

0 references

author name string

Joe Gray

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dipankar Chattopadhyay

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Gary S Beale

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Gillian L Patman

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Barry P King

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Stephen Stewart

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Mark Hudson

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Christopher P Day

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Derek M Manas

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Helen L Reeves

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

5 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

271

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Bone morphogenetic protein-1 (BMP-1) cleaves human proapolipoprotein A1 and regulates its activation for lipid binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

A role for human Sp alpha as a pattern recognition receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Liver cancer on the rise

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Primary liver cancer: worldwide incidence and trends

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729079

21 June 2018

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

Alphafetoprotein: an obituary.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

A novel panel of blood markers to assess the degree of liver fibrosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

Alpha-2-macroglobulin and hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-271

21 January 2018

Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in primary liver cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Factors influencing the success rate and stability of transient elastography for liver fibrosis evaluation]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical inference methods for detecting altered gene associations

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do not trivialize the Fibroscan examination, value its accuracy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19656391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-9-271

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33490839&oldid=2195410627"